Louis J. Aronne

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

L. Aronne, C. Molony, S. Heymsfield, 2010, International Journal of Obesity.

Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies.

L. Aronne, W. Brown, Kathy Isoldi, 2007, Journal of clinical lipidology.

Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats.

L. Aronne, C. Boozer, M. C. Cha, 2001, Metabolism: clinical and experimental.

Epidemiology, morbidity, and treatment of overweight and obesity.

Louis J. Aronne, 2001, The Journal of clinical psychiatry.

Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial

F. Greenway, K. Fujioka, L. Aronne, 2008, International Journal of Obesity.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

John E. Poremba, H. Randeva, P. Borne, 2024, The Lancet.